DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control

by Esther W Y Chan, Emily T Y Tse, Cindy L K Lam
Published 2020-04-01

Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients...

by Carlos K H Wong, Kenneth K C Man, Margaret Shi, Esther W Chan, Chu Wa Ho, Emily T Y Tse, Ian C K Wong, Cindy L K Lam
Published 2019-12-01